DDP225

DRUG2 trials

Sponsors

Dynogen Pharmaceuticals

Conditions

Irritable Bowel SyndromeVomiting

Phase 2

8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS

CompletedNCT00230581

Dynogen PharmaceuticalsIrritable Bowel Syndrome

Start: 2005-09-30End: 2007-08-31Target: 88Updated: 2007-10-15

12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting

TerminatedNCT00252993

Dynogen PharmaceuticalsVomiting

Start: 2005-11-30End: 2006-03-31Target: 30Updated: 2007-10-12